HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Details 詳細情報について

• CRID

  1360857597686008192

• DOI

  10.1016/j.annonc.2020.04.004

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753420392954?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753420392954?httpAccept=text/plain

• Data Source

  • Crossref